| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on January 13, 2009
From the Department of Clinical Sciences (P.M.N.), Lund University, University Hospital, Malmö, Sweden; Université Paris-Descartes (P.B., S.L.), Paris, France; Department of Pharmacology (P.B., S.L.), Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris France; and the Institut National de la Santé et de la Recherche Médicale U 970 (P.B., S.L.), Paris, France. * To whom correspondence should be addressed. E-mail: Peter.Nilsson{at}med.lu.se.
Revised on February 4, 2009
Vascular Aging. A Tale of EVA and ADAM in Cardiovascular Risk Assessment and Prevention
Peter M. Nilsson*;
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |